Rheumatology NewsFDA Approves Ustekinumab Biosimilar Steqeyma, the Seventh of Its KindDecember 19, 2024Psoriatic Arthritis
Rheumatology NewsDuloxetine Bottles Recalled by FDA Because of Potential CarcinogenOctober 28, 2024Pain
Rheumatology NewsFDA Approves Ustekinumab Biosimilar OtulfiOctober 3, 2024Psoriatic ArthritisPediatrics
Rheumatology NewsBimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsBenralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19, 2024Lupus & Connective Tissue DiseasesVasculitis
Rheumatology NewsPyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Psoriatic ArthritisPediatrics
Rheumatology NewsFDA Grants New Pediatric Arthritis Indications for UpadacitinibJune 7, 2024Pediatrics
Rheumatology NewsBelimumab Autoinjector Approved for Pediatric LupusMay 22, 2024Lupus & Connective Tissue DiseasesPediatrics
Rheumatology NewsFDA OKs First-in-Class Agent for Pulmonary Arterial HypertensionMarch 28, 2024Lupus & Connective Tissue Diseases
Rheumatology NewsNew Cancer Surgical Tech Gets Positive Vote, But Some Cite Safety ConcernsMarch 8, 2024
Rheumatology NewsSecond FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous FormulationsMarch 8, 2024Rheumatoid ArthritisLupus & Connective Tissue DiseasesPediatrics
Rheumatology NewsFirst Denosumab Biosimilar Approved in Two Different FormulationsMarch 6, 2024Osteoporosis
Rheumatology NewsFDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPediatrics
